Valgen Medtech Revenue and Competitors
Estimated Revenue & Valuation
- Valgen Medtech's estimated annual revenue is currently $2.8M per year.
- Valgen Medtech's estimated revenue per employee is $251,000
Employee Data
- Valgen Medtech has 11 Employees.
- Valgen Medtech grew their employee count by -39% last year.
Valgen Medtech's People
Name | Title | Email/Phone |
---|
Valgen Medtech Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Valgen Medtech?
唯强医疗,国际å‰æ²¿çš„医疗器械集团,致力于为严é‡å¨èƒäººç±»å¥åº·ä½†ç›®å‰ç¼ºä¹æœ‰æ•ˆæ‰‹æ®µçš„é‡å¤§ç–¾ç—…寻求有效治疗方案。 唯强医疗致力于创新性产å“çš„ç ”å‘,目å‰æ‹¥æœ‰å…¨è‚ºå¾®åˆ›ç²¾ç¡®è¯Šç–—å¹³å°ã€å¤–周血管介入ã€ç»“构性心è„病介入ã€å¿ƒè„瓣膜修å¤ã€å¿ƒè¡°ç‰å多个项目,涵盖心血管和周围血管微创介入åŠè‚ºéƒ¨è¯Šç–—领域,在ä¸å›½æ·±åœ³ã€ç¾Žå›½ã€ä»¥è‰²åˆ—ã€é¦™æ¸¯å‡è®¾æœ‰å¤šä¸ªç ”å‘ä¸å¿ƒã€‚员工总数近åƒäººï¼Œå…¶ä¸è¶…过15%海外员工。 唯强目å‰æ‹¥æœ‰å„类专利1000多个。自2012年以æ¥ï¼Œå¼•è¿›æŠ•èµ„超过6亿美元,2018年开始实现销售,2019年集团销售3.8亿人民å¸ï¼Œé¢„计2020年达到8亿,2022å¹´çªç ´20亿。 唯强医疗已上市和已ç»èŽ·å¾—风险投资ä¼ä¸šæ€»å¸‚值近300亿,有望在2022年实现以3家上市公å¸ä¸ºä¸»ä½“超过15家ä¼ä¸šçš„集团,总市值有望çªç ´1000亿的医疗器械集团。 总部æ州现有17000å¹³ç±³çš„ç ”å‘和生产基地,预计三年åŽä¼šå»ºæˆå”¯å¼ºè‡ªæœ‰äº§ä¸šå›ï¼Œä¸´è¿‘钱塘江,å 地65亩。银行ã€è·‘é“ã€å¥èº«æˆ¿ã€é¤åŽ…ã€æ‰˜å„¿æ‰€ç‰å„ç§é…套设施都将入驻å›åŒºã€‚å›åŒºä¸è¿˜åŒ…å«æœ‰37亩的水系公å›ä½œä¸ºå”¯å¼ºåŽèŠ±å›ã€‚ 欢迎敢想敢拼的åŽæµªå¥”腾而æ¥~
keywords:N/AN/A
Total Funding
11
Number of Employees
$2.8M
Revenue (est)
-39%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 12 | -48% | N/A |
#2 | $1.2M | 14 | -26% | N/A |
#3 | N/A | 34 | -23% | N/A |
#4 | N/A | 34 | -11% | N/A |
#5 | $6.9M | 43 | 0% | N/A |